Article
Gastrointestinal stromal tumors, version 2.2014.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jun 2014
von Mehren Margaret, Randall R Lor, Benjamin Robert S, Boles Sarah, Bui Marilyn M, Casper Ephraim S, Conrad Ernest U, DeLaney Thomas F, Ganjoo Kristen N, George Suzanne, Gonzalez Ricardo J, Heslin Martin J, Kane John M, Mayerson Joel, McGarry Sean V, Meyer Christian, O'Donnell Richard J, Pappo Alberto S, Paz I Benjamin, Pfeifer John D, Riedel Richard F, Schuetze Scott, Schupak Karen D, Schwartz Herbert S, Van Tine Brian A, Wayne Jeffrey D, Bergman Mary Anne, Sundar Hema
Abstract excerpt
Gastrointestinal stromal tumors (GIST) are the most common soft tissue sarcoma of the gastrointestinal tract, resulting most commonly from KIT or platelet-derived growth factor receptor α (PDGFRα)-activating mutations. These NCCN Guideline Insights highlight the important updates to the NCCN Guidelines for Soft Tissue Sarcoma specific to the management of patients with GIST experiencing disease progression while...
Topics
Join the communities discussing this publication.